- Home
- PVLA vs GEVO Comparison
PVLA vs GEVO Comparison
Compare PVLA & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- GEVO
- Stock Information
- Founded
- PVLA 2015
- GEVO 2005
- Country
- PVLA United States
- GEVO United States
- Employees
- PVLA N/A
- GEVO N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- GEVO Major Chemicals
- Sector
- PVLA Health Care
- GEVO Industrials
- Exchange
- PVLA Nasdaq
- GEVO Nasdaq
- Market Cap
- PVLA 308.2M
- GEVO 330.4M
- IPO Year
- PVLA N/A
- GEVO 2011
- Fundamental
- Price
- PVLA $24.36
- GEVO $1.20
- Analyst Decision
- PVLA Strong Buy
- GEVO Buy
- Analyst Count
- PVLA 7
- GEVO 2
- Target Price
- PVLA $44.43
- GEVO $7.58
- AVG Volume (30 Days)
- PVLA 97.9K
- GEVO 3.0M
- Earning Date
- PVLA 05-15-2025
- GEVO 05-01-2025
- Dividend Yield
- PVLA N/A
- GEVO N/A
- EPS Growth
- PVLA N/A
- GEVO N/A
- EPS
- PVLA N/A
- GEVO N/A
- Revenue
- PVLA N/A
- GEVO $16,915,000.00
- Revenue This Year
- PVLA N/A
- GEVO $486.56
- Revenue Next Year
- PVLA N/A
- GEVO $143.67
- P/E Ratio
- PVLA N/A
- GEVO N/A
- Revenue Growth
- PVLA N/A
- GEVO N/A
- 52 Week Low
- PVLA $6.20
- GEVO $0.48
- 52 Week High
- PVLA $29.27
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- GEVO 49.52
- Support Level
- PVLA N/A
- GEVO $1.11
- Resistance Level
- PVLA N/A
- GEVO $1.20
- Average True Range (ATR)
- PVLA 0.00
- GEVO 0.09
- MACD
- PVLA 0.00
- GEVO 0.02
- Stochastic Oscillator
- PVLA 0.00
- GEVO 96.55
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.